A lthough regenerative medicine is a relatively new field of biomedical research, its application to organ reconstruction provides a promising therapeutic option. Regenerative therapeutics may provide cures to patients with various ailments by replacing or regenerating human tissues or organs to restore normal physiological functions. 1 A wide range of biomedical engineering approaches have been pursued for regenerative therapies, and some have led to clinical applications. Regardless of the approach, acquiring an adequate source of cells is an important prerequisite. Stem cells, defined by their inherent ability to self-renew continuously, or to differentiate into a multitude of different cell types, are thus a highly promising choice for regenerative medicine. 1 Although the extensive research on utilizing stem cells for regenerative medicine has resulted in remarkable discoveries, there are still major hurdles that need to be overcome before stem cells can become a viable source of cells for regenerative medicine. Aside from the ethical concerns associated with embryonic stem cells, the precise control of stem cell fate, self-renewal or differentiation into specific cell types, has been a glaring challenge for scientists and engineers.
To control stem cell differentiation, researchers have traditionally relied on twodimensional (2D) surfaces for culture. However, research over the last few decades has shown that stem cells reside in a complex microenvironment, and their fate is determined by several factors, such as soluble and physical signals from extracellular matrix (ECM) and neighboring cells ( Figure 1 ). 2 Moreover, these factors are spatially and temporally controlled. To mimic the native microenvironment of stem cells with the ultimate goal of directing their self-renewal and differentiation outcomes, more researchers are now utilizing biomaterialsbased approaches.
Biomaterials PERSPECTIVE that induce differentiation, others have been shown to maintain pluripotency of stem cells. 20 Due to the difficulties associated with synthesizing and purifying such proteins, there have been increasing efforts to use small molecules that can replace the function of signaling proteins. Synthetic or naturally occurring chemicals have proven to be potent regulators of stem cell differentiation: several of them, either by themselves or in combination with other biological factors, have now become standard tools for differentiating stem cells. For instance, a cocktail of dexamethasone, ascorbic acid, and β-glycerophosphate is commonly used to induce osteogenic differentiation. 21 Also, 5-azacytidine, a chemotherapeutic agent, has been shown to induce cardiomyogenic differentiation. 22 To identify such small molecules, chemical libraries are increasingly being screened to identify molecules that can direct cell fate decisions in a reproducible and scalable manner.
Stimulating stem cells with soluble factors has been the conventional method for regulating stem cells phenotypes. It is, however, becoming increasingly appreciated that providing these soluble factors in the context of biomaterials could further enhance our ability to direct stem cells. This is due to a number of factors, such as slower release of soluble factors encapsulated within biomaterials, which prolongs their bioavailability and efficacy. 23 In addition, the release of these factors from microscale reservoirs may generate localized gradients, which may be more biologically relevant. For example, TGF-β1 encapsulated in microparticles has been shown to direct chondrogenic differentiation of MSCs in hydrogel matrices. Controlling the substrate elasticity is one major advantage of using biomaterials. Conventional plasticbased 2D tissueÀculture platforms do not allow the control of surface elasticity, and its rigidity (∼3 GPa) is PERSPECTIVE not physiologically relevant. On the other hand, the elasticities of soft biomaterials such as hydrogels and polymeric scaffolds are within the range of biological tissues and can be readily controlled by varying the cross-linking density via concentrations of polymers or cross-linking molecules.
A New Paradigm in Biomaterial Design-Targeting Glycosaminoglycans (GAGs) To Regulate Stem Cell Fate. In line with previously stated methods of using engineered biomaterials to direct stem cell differentiation, it is important to utilize novel signaling mechanisms and biological tools. An emerging class of molecules for directing cellular behavior are glycosaminoglycans (GAGs), which are linear polysaccharides that are present on the cell surface and in the ECM. 29, 30 It is known that cellsurface proteoglycans (heavily glycosylated proteins), which project their GAG components outward, can mediate physical cues from ECM to influence cell phenotypes. Thus, it may be possible to use cellsurface GAGs to regulate various cellular activities. Recently, Kiessling and co-workers developed an array of self-assembled monolayers that present several different types of GAG-binding peptides and their combinations derived from ECM proteins, and demonstrated that proliferation and differentiation of stem cells could be mediated by GAG-binding peptides. 31 In this issue of ACS Nano, Kiessling and co-workers present a novel biomaterial design strategy that incorporates GAG-binding peptides as cell-responsive ligands into a biomaterial to mediate physical cues imparted by the material elasticity ( Figure 3) . 32 In this research, they utilized a chemical modification strategy to conjugate a GAGbinding peptide derived from vitronectin, GKKQRFRHRNRKG, onto a hydrogel surface. Stem cells were able to adhere and to proliferate on the hydrogel surface while maintaining their pluripotency without other integrin-binding ligands such as RGD peptides, confirming that GAG-binding peptides act as a potent bioactive ligand for stem cells. More significantly, the proliferative capacity of stem cells could be controlled by the elasticity of hydrogel substrate, in which increasing hydrogel stiffness resulted in 
FUTURE OUTLOOK
Many recent contributions have shed light on the complex systems of mechanical and chemical spatiotemporal cues that regulate stem cell differentiation. However, much work remains before we can rationally design synthetic materials capable of providing autonomous direction to pluripotent stem cell populations. Insightful contributions, like those from Kiessling and colleagues, that connect the extracellular environment to changes in stem cell gene expression represent key advances in our ability to establish design parameters for biomaterials in regenerative medicine. To realize the goals of regenerative medicine ; to replace or to regenerate aged, injured, or diseased organs or tissues ; concerted efforts are required from biomaterials scientists and stem-cell biologists. This work is an exciting and vibrant area of research at the interface of stem-cell biology and materials chemistry. Using synthetic materials to recapitulate reliable and instructive stemcell niches will require distensible command of fluid transport, bioactive molecule incorporation, surface chemistries that facilitate cellÀ matrix and cellÀcell interactions, and degradation/elimination mechanisms. From stem-cell biologists, future advances in this area will require further identification of rapidly accessible biomarkers to discriminate between stem cells and their differentiated progeny as well as a more mechanistic understanding of the biological cues that regulate stem cell fate decisions. 
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